DXCM EBITDA Growth
Dexcom · EBITDA Growth
DXCM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported50.03%period ending
DXCM TTM EBITDA YoY % (-49.50% → 50.03%)
Year-over-year change
High-resolution chart · PNG
DXCM ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 50.0289% | |
| 51.6973% | |
| 43.6502% | |
| 25.3358% | |
| 0.7563% | |
| -2.0591% | |
| 3.1635% | |
| 23.8791% | |
| 50.8336% | |
| 66.3492% | |
| 61.9325% | |
| 80.9469% | |
| 86.8817% | |
| 62.7686% | |
| 58.883% | |
| -0.9786% | |
| -16.1741% | |
| -6.4138% | |
| -5.4406% | |
| 17.3611% | |
| 32.1526% | |
| 47.8179% | |
| 76.7355% | |
| 628.8136% | |
| 479.2193% | |
| 519.9052% | |
| 385.4083% | |
| -168.8047% | |
| -268.472% | |
| -2,078.125% | |
| -279.1878% | |
| 355.335% | |
| 184.8933% | |
| 104.5977% | |
| 59.9593% | |
| 2.8916% | |
| 8.9686% | |
| -34.3629% | |
| -6.0345% | |
| 11.7021% | |
| -562.3762% | |
| -298.4615% | |
| -254.1985% | |
| -168.5714% | |
| 46.2766% | |
| 43.9655% | |
| 40.1826% | |
| 37.6025% | |
| 51.9747% | |
| 47.3278% | |
| 55.4389% | |
| 47.8573% | |
| 23.0409% | |
| 0.2084% | |
| -19.9385% | |
| -37.8659% | |
| -27.8137% | |
| 0.2012% | |
| 20.686% | |
| 24.1416% | |
| 19.2185% | |
| 13.3636% | |
| -19.7649% | |
| -11.8505% | |
| -2.1544% | |
| -6.0054% | |
| 12.4033% | |
| 5.0823% | |
| -4.7685% | |
| -9.0413% | |
| -13.6143% | |
| -12.6701% | |
| -0.2364% | |
| 6.1891% | |
| 5.5299% | |
| 9.2935% | |
| -13.0965% | |
| -34.7731% | |
| -49.4963% |